These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2773899)

  • 1. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Campylobacter pylori does not alter gastric acid secretion.
    Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
    Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
    Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
    Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology and therapy of Campylobacter pylori infection].
    Wagner S; Freise J; Bär W; Fritsch S; Schmidt FW
    Dtsch Med Wochenschr; 1989 Mar; 114(11):407-13. PubMed ID: 2707124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
    Elta GH; Murphy R; Behler EM; Barnett JL; Nostrant TT; Kern S; Appelman H
    Am J Gastroenterol; 1989 Jun; 84(6):643-6. PubMed ID: 2729235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with Campylobacter pylori in western Kentucky.
    Kraus JW; Morello PJ
    J Ky Med Assoc; 1989 Sep; 87(9):448-50. PubMed ID: 2794757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
    Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
    Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis].
    Stanescu A; Malfertheiner P; Mayer D; Baczako K; Ditschuneit H
    Fortschr Med; 1989 Oct; 107(29):623-6. PubMed ID: 2680842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 18. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
    McNulty CA; Gearty JC; Crump B; Davis M; Donovan IA; Melikian V; Lister DM; Wise R
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):645-9. PubMed ID: 3092967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
    Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
    Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.